Pharmaceutical Preparations
Standard Industrial Classification: SIC 2834
Industry Insider Sentiment Analysis
The Pharmaceutical Preparations sector (SIC 2834) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-12 21:09 | 2026-06-11 | SNDX | Syndax Pharmaceuticals Inc | Botwood Nicholas A.J. | Officer | OPT+S | $18.07 | 65,515 | $1,183,640 | 60,885 |
| 2026-06-12 21:15 | 2026-06-11 | QURE | uniQure N.V. | Jacques Rachelle Suzanne | Director | SELL | $27.06 | 1,993 | $53,931 | 33,903 |
| 2026-06-12 20:30 | 2026-06-10 | LQDA | Liquidia Corp | Bloch Stephen M | Director | SELL | $68.61 | 388,223 | $26,634,777 | 1,176,184 |
| 2026-06-12 19:33 | 2026-06-11 | ADTX | Aditxt, Inc. | HRT FINANCIAL LP | 10% owner | SELL | $0.01 | 2,833,463 | $39,668 | 0 |
| 2026-06-12 18:35 | 2026-06-12 | SMMT | Summit Therapeutics Inc. | Zanganeh Mahkam | Director, Officer, 10% owner | BUY | $13.12 | 3,810,000 | $49,987,200 | 573,883,879 |
| 2026-06-12 16:28 | 2026-06-12 | SMMT | Summit Therapeutics Inc. | DUGGAN ROBERT W | Director, Officer, 10% owner | BUY | $13.12 | 3,810,000 | $49,987,200 | 573,883,879 |
| 2026-06-11 20:23 | 2026-06-10 | LLY | ELI LILLY & Co | Yuffa Ilya | Officer | SELL | $1,150.77 | 2,500 | $2,876,925 | 29,804 |
| 2026-06-11 20:07 | 2026-06-10 | LYEL | Lyell Immunopharma, Inc. | Shook David | Officer | SELL | $12.64 | 1,977 | $24,989 | 20,923 |
| 2026-06-11 20:30 | 2026-06-10 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Kung Winston | Director | SELL | $7.91 | 2,026 | $16,033 | 12,140 |
| 2026-06-11 20:30 | 2026-06-10 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Jenkins John Kenneth | Director | SELL | $7.91 | 4,800 | $37,986 | 3,833 |
| 2026-06-11 20:30 | 2026-06-10 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Altmeyer Anne | Director | SELL | $7.91 | 2,412 | $19,088 | 7,579 |
| 2026-06-12 00:34 | 2026-06-10 | AXSM | Axsome Therapeutics, Inc. | JEFFS ROGER | Director | SELL | $247.65 | 572 | $141,656 | 58,367 |
| 2026-06-12 00:13 | 2026-06-09 | HOWL | Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% owner | SELL | $0.37 | 678,226 | $253,589 | 361,229 |
| 2026-06-12 00:02 | 2026-06-09 | NUVB | Nuvation Bio Inc. | Mashal Robert | Director | BUY | $4.73 | 25,000 | $118,250 | 225,000 |
| 2026-06-11 23:28 | 2026-06-05 | NATR | NATURES SUNSHINE PRODUCTS INC | Yates Bryant J | Officer | SELL | $19.90 | 11,968 | $238,163 | 77,446 |
| 2026-06-11 23:06 | 2026-06-10 | PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Director | OPT+S | $107.68 | 9,000 | $969,120 | 7,825 |
| 2026-06-11 21:00 | 2026-06-09 | STTK | Shattuck Labs, Inc. | SIEGALL CLAY B | Director | BUY | $4.00 | 62,500 | $250,000 | 318,608 |
| 2026-06-11 20:30 | 2026-06-09 | NUVL | Nuvalent, Inc. | Noci Darlene | Officer | OPT+S | $122.81 | 20,000 | $2,456,200 | 58,117 |
| 2026-06-11 20:34 | 2026-06-10 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Director, Officer | OPT+S | $545.83 | 9,500 | $5,185,365 | 40,513 |
| 2026-06-11 20:01 | 2026-06-09 | GYRE | GYRE THERAPEUTICS, INC. | Ye Weiguo | Officer | OPT+S | $6.16 | 20,918 | $128,886 | 700,000 |
| 2026-06-11 19:09 | 2026-06-09 | ADTX | Aditxt, Inc. | HRT FINANCIAL LP | 10% owner | SELL | $0.03 | 878,659 | $28,996 | 314,674 |
| 2026-06-11 19:09 | 2026-06-08 | ADTX | Aditxt, Inc. | HRT FINANCIAL LP | 10% owner | BUY | $0.04 | 2,148,823 | $83,589 | 1,040,004 |
| 2026-06-10 20:05 | 2026-06-08 | INSM | INSMED Inc | Lewis William | Director, Officer | SELL | $94.03 | 6,515 | $612,605 | 258,917 |
| 2026-06-11 01:51 | 2026-06-09 | ADTX | Aditxt, Inc. | Gong Sandie | 10% owner | SELL | $0.07 | 100,000 | $6,880 | 0 |
| 2026-06-11 01:49 | 2026-06-10 | AXSM | Axsome Therapeutics, Inc. | Coleman Mark | Director | OPT+S | $249.00 | 643 | $160,107 | 30,389 |
| 2026-06-11 01:49 | 2026-06-09 | AXSM | Axsome Therapeutics, Inc. | Mahony Susan | Director | OPT+S | $241.70 | 600 | $145,017 | 829 |
| 2026-06-11 01:06 | 2026-06-08 | ANIP | ANI PHARMACEUTICALS INC | HAUGHEY THOMAS | Director | SELL | $80.88 | 2,000 | $161,760 | 38,878 |
| 2026-06-11 01:14 | 2026-05-20 | INM | InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC | 10% owner | BUY | $1.57 | 249,227 | $391,561 | 72,535 |
| 2026-06-11 00:26 | 2026-06-08 | CVKD | Cadrenal Therapeutics, Inc. | Pham Quang X | Director, Officer, 10% owner | SELL | $4.17 | 22,385 | $93,294 | 150,839 |
| 2026-06-10 23:58 | 2026-06-09 | PFE | PFIZER INC | DAMICO JENNIFER B. | Officer | SELL | $25.70 | 2,000 | $51,400 | 31,397 |
| 2026-06-10 21:20 | 2026-06-09 | HOWL | Werewolf Therapeutics, Inc. | EVNIN LUKE | Director | SELL | $0.37 | 76,928 | $28,463 | 300,283 |
| 2026-06-10 21:22 | 2026-06-08 | ONC | BeOne Medicines Ltd. | OYLER JOHN | Director, Officer | SELL | $270.56 | 4,940 | $1,336,548 | 0 |
| 2026-06-10 21:23 | 2026-06-08 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Officer | SELL | $269.37 | 1,484 | $399,738 | 0 |
| 2026-06-10 21:25 | 2026-06-08 | ONC | BeOne Medicines Ltd. | Wang Lai | Officer | SELL | $269.38 | 1,367 | $368,247 | 0 |
| 2026-06-10 21:26 | 2026-06-08 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | Officer | SELL | $270.42 | 871 | $235,539 | 0 |
| 2026-06-10 21:27 | 2026-06-08 | ONC | BeOne Medicines Ltd. | Ball Titus B. | Officer | SELL | $271.33 | 136 | $36,901 | 0 |
| 2026-06-10 21:06 | 2026-06-09 | MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | ORESHACK KURT | Officer | SELL | $5.08 | 50,000 | $254,000 | 335,767 |
| 2026-06-10 20:42 | 2026-06-09 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Director, Officer | OPT+S | $549.32 | 9,500 | $5,218,534 | 40,513 |
| 2026-06-10 20:30 | 2026-06-08 | LQDA | Liquidia Corp | Bloch Stephen M | Director | SELL | $64.64 | 220,835 | $14,273,692 | 1,564,407 |
| 2026-06-10 20:30 | 2026-06-08 | NUVL | Nuvalent, Inc. | Porter James Richard | Director, Officer | OPT+S | $88.53 | 30,000 | $2,656,005 | 324,879 |
| 2026-06-10 20:31 | 2026-06-08 | LQDA | Liquidia Corp | Khindri Sanjeev | Officer | SELL | $65.46 | 4,134 | $270,612 | 67,132 |
| 2026-06-10 10:04 | 2026-06-08 | INDV | Indivior Pharmaceuticals, Inc. | Preblick Ryan | Officer | SELL | $37.70 | 36,000 | $1,357,200 | 284,751 |
| 2026-06-09 21:06 | 2026-06-08 | DYN | Dyne Therapeutics, Inc. | Posner Brian S | Director | BUY | $16.94 | 2,000 | $33,880 | 24,500 |
| 2026-06-10 01:21 | 2026-06-08 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | Officer | OPT+S | $93.82 | 5,000 | $469,077 | 44,788 |
| 2026-06-10 00:32 | 2026-06-08 | ABEO | ABEONA THERAPEUTICS INC. | Seshadri Vishwas | Director, Officer | SELL | $5.36 | 56,344 | $301,919 | 1,374,079 |
| 2026-06-10 00:32 | 2026-06-08 | ABEO | ABEONA THERAPEUTICS INC. | Vasanthavada Madhav | Officer | SELL | $5.36 | 9,620 | $51,549 | 303,451 |
| 2026-06-10 00:32 | 2026-06-08 | ABEO | ABEONA THERAPEUTICS INC. | Vazzano Joseph Walter | Officer | SELL | $5.38 | 49,338 | $265,241 | 518,437 |
| 2026-06-10 00:32 | 2026-06-08 | ABEO | ABEONA THERAPEUTICS INC. | O'Malley Brendan M. | Officer | SELL | $5.36 | 11,131 | $59,645 | 440,003 |
| 2026-06-09 22:33 | 2026-06-05 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | Officer | OPT+S | $80.00 | 3,312 | $264,960 | 180,393 |
| 2026-06-09 22:06 | 2026-06-08 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | Officer | OPT+S | $547.50 | 10,000 | $5,475,045 | 18,876 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Pharmaceutical Preparations sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (2834) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Pharmaceutical Preparations
Every transaction in the Pharmaceutical Preparations industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.